Cargando…

Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients

Aberrant glycosylation actively contributes to tumor progression and is a key hallmark of cancer. Most of the glycan moieties expressed on the surface of cancer cells are sialic acids that may modulate antitumor immune responses via binding to sialic acid–binding immunoglobulin-like lectins (Siglecs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benmerzoug, Sulayman, Chevalier, Mathieu F., Villier, Laura, Nguyen, Sylvain, Cesson, Valérie, Schneider, Anna K., Dartiguenave, Florence, Rodrigues-Dias, Sonia-Christina, Lucca, Ilaria, Jichlinski, Patrice, Roth, Beat, Nardelli-Haefliger, Denise, Derré, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Brief Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605422/ https://www.ncbi.nlm.nih.gov/pubmed/34825225 http://dx.doi.org/10.1016/j.euros.2021.10.001

Ejemplares similares

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
por: Nguyen, Sylvain, et al.
Publicado: (2022)

Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile
por: Lucca, Ilaria, et al.
Publicado: (2022)

Double Positive CD4(+)CD8(+) T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization
por: Bohner, Perrine, et al.
Publicado: (2019)

Immunotherapeutic strategies for bladder cancer
por: Chevalier, Mathieu F, et al.
Publicado: (2014)

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells
por: Decrausaz, Loane, et al.
Publicado: (2013)

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients
por: Pieraerts, Claire, et al.
Publicado: (2012)

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
por: Domingos-Pereira, Sonia, et al.
Publicado: (2022)

What is the influence of vaccination’s routes on the regression of tumors located at mucosal sites?
por: Nardelli-Haefliger, Denise, et al.
Publicado: (2012)

Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion
por: Alonso, Florian, et al.
Publicado: (2016)

Intravaginal TLR agonists increase local vaccine-specific CD8 T-cells and human papillomavirus-associated genital-tumor regression in mice
por: Domingos-Pereira, Sonia, et al.
Publicado: (2012)

Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer
por: Hojeij, Rim, et al.
Publicado: (2016)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

ERAS® protocol improves survival after radical cystectomy: A single-center cohort study
por: Crettenand, François, et al.
Publicado: (2022)

Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
por: Ahmed, Ritaparna, et al.
Publicado: (2023)

Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth
por: Sathiyanadan, Karthik, et al.
Publicado: (2022)

Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication
por: Zhao, Di, et al.
Publicado: (2018)

Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans
por: Rosenstock, Philip, et al.
Publicado: (2017)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec‐7
por: Fan, Tianrui, et al.
Publicado: (2022)

Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells
por: Adeniji, Opeyemi S., et al.
Publicado: (2021)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2
por: Saini, Pratima, et al.
Publicado: (2023)

Is EDSS Enough to Predict Risk of Upper Urinary Tract Damage in Patients with Multiple Sclerosis?
por: Stritt, Kevin, et al.
Publicado: (2022)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

Hippocampal interleukin-33 mediates neuroinflammation-induced cognitive impairments
por: Reverchon, Flora, et al.
Publicado: (2020)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
por: Daly, John, et al.
Publicado: (2019)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Siglecs in Brain Function and Neurological Disorders
por: Siddiqui, Shoib Sarwar, et al.
Publicado: (2019)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14
por: Murch, Simon H.
Publicado: (2020)

Cytokine-induced killer cells promote antitumor immunity
por: Jiang, Jingting, et al.
Publicado: (2013)

Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus
por: Ali, Syed Raza, et al.
Publicado: (2014)

Comparison of (68)Ga-DOTA-Siglec-9 and (18)F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry
por: Virtanen, Helena, et al.
Publicado: (2017)

Increased Frequency of Dysfunctional Siglec-7(−)CD57(+)PD-1(+) Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease
por: Sakamoto, Yuzuru, et al.
Publicado: (2021)

Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer
por: Lv, Kunpeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_do89k2dpsj95g1cj9fumpdd7tp